Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 1
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck Cancer.
Badarni M, Prasad M, Golden A, Bhattacharya B, Levin L, Yegodayev KM, Dimitstein O, Joshua BZ, Cohen L, Khrameeva E, Kong D, Porgador A, Braiman A, Grandis JR, Rotblat B, Elkabets M. Badarni M, et al. Among authors: yegodayev km. Cancers (Basel). 2021 May 7;13(9):2250. doi: 10.3390/cancers13092250. Cancers (Basel). 2021. PMID: 34067117 Free PMC article.
Assessment of parathyroid gland cellularity by digital slide analysis.
Sagiv R, Delgado B, Lavon O, Osipov V, Sade R, Shashar S, Yegodayev KM, Elkabets M, Joshua BZ. Sagiv R, et al. Among authors: yegodayev km. Ann Diagn Pathol. 2022 Jun;58:151907. doi: 10.1016/j.anndiagpath.2022.151907. Epub 2022 Jan 31. Ann Diagn Pathol. 2022. PMID: 35299079
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
Prasad M, Zorea J, Jagadeeshan S, Shnerb AB, Mathukkada S, Bouaoud J, Michon L, Novoplansky O, Badarni M, Cohen L, Yegodayev KM, Tzadok S, Rotblat B, Brezina L, Mock A, Karabajakian A, Fayette J, Cohen I, Cooks T, Allon I, Dimitstein O, Joshua B, Kong D, Voronov E, Scaltriti M, Carmi Y, Conde-Lopez C, Hess J, Kurth I, Morris LGT, Saintigny P, Elkabets M. Prasad M, et al. Among authors: yegodayev km. J Immunother Cancer. 2022 Mar;10(3):e003917. doi: 10.1136/jitc-2021-003917. J Immunother Cancer. 2022. PMID: 35292516 Free PMC article.